Bristol-Myers Squibb Provides Update on Pending Transaction with Celgene
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.12 -0.46 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.58 | 52 Week High | $77.12 | |||
| Open | $58.88 | 52 Week Low | $49.03 | |||
| Day High | $59.79 | P/E | 38.39 | |||
| Day Low | $58.74 | EPS | $1.54 | |||
| Volume | 9,253,469 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
